FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048654315> ?p ?o ?g. }

• W3048654315 endingPage "10" @default.
• W3048654315 startingPage "2" @default.
• W3048654315 abstract "Basal cell carcinoma is the most common skin tumour, with the majority of the cases occurring on the head and neck district, where cosmetic and functional results are crucial. It can be locally destructive if not diagnosed early and treated appropriately. Surgery is the treatment of choice for most lesions, but aggressive, recurrent, or unresectable tumours can be challenging to manage. Advanced basal cell carcinoma includes high recurrence risk subtypes, in which standard therapies demonstrate lack of efficacy. This led to a need for investigating more deeply the pathogenesis of the disease and to the discovery of the implication of the hedgehog pathway. The development of systemic inhibitors of this pathway provides new treatment options for patients with advanced disease, resulting in survival improvement. Food and Drug Administration, before, and European Medicines Agency later approved 2 Hedgehog pathway inhibitors for the treatment of advanced basal cell carcinomas, vismodegib and sonidegib. Here, we present a review of the current English language literature trying to analyze differences in the 2 drugs as a head-to-head comparison between them has not already been documented in a randomized controlled clinical trial. Although vismodegib and sonidegib showed similar efficacy and safety profiles, in an indirect comparison scenario, sonidegib has shown slightly better outcomes in locally advanced basal cell carcinoma than vismodegib. They present different molecular structures, as they bind different residues on their targets and develop resistance for different mutations. In a future scenario, clinical trials comparing the 2 drugs are needed, as well as expanding data on discontinuation of therapy and/or consequential administration of them, with the aim to improve our clinical practise." @default.
• W3048654315 created "2020-08-18" @default.
• W3048654315 creator A5002719929 @default.
• W3048654315 creator A5004401304 @default.
• W3048654315 creator A5006307929 @default.
• W3048654315 creator A5007806653 @default.
• W3048654315 creator A5025847886 @default.
• W3048654315 creator A5028712141 @default.
• W3048654315 creator A5040002157 @default.
• W3048654315 creator A5044074313 @default.
• W3048654315 creator A5059728206 @default.
• W3048654315 creator A5086252442 @default.
• W3048654315 creator A5086793471 @default.
• W3048654315 creator A5089821412 @default.
• W3048654315 date "2020-01-01" @default.
• W3048654315 modified "2023-10-16" @default.
• W3048654315 title "High-Risk Recurrence Basal Cell Carcinoma: Focus on Hedgehog Pathway Inhibitors and Review of the Literature" @default.
• W3048654315 cites W1941928051 @default.
• W3048654315 cites W1963750572 @default.
• W3048654315 cites W1970915933 @default.
• W3048654315 cites W197200585 @default.
• W3048654315 cites W1974218353 @default.
• W3048654315 cites W1984445615 @default.
• W3048654315 cites W1984999562 @default.
• W3048654315 cites W1986178062 @default.
• W3048654315 cites W1990453562 @default.
• W3048654315 cites W1995143994 @default.
• W3048654315 cites W2002249795 @default.
• W3048654315 cites W2003026510 @default.
• W3048654315 cites W2006275842 @default.
• W3048654315 cites W2008976442 @default.
• W3048654315 cites W2019607817 @default.
• W3048654315 cites W2024150672 @default.
• W3048654315 cites W2034984204 @default.
• W3048654315 cites W2035657135 @default.
• W3048654315 cites W2036833206 @default.
• W3048654315 cites W2048774760 @default.
• W3048654315 cites W2050569781 @default.
• W3048654315 cites W2057810696 @default.
• W3048654315 cites W2063372123 @default.
• W3048654315 cites W2091113670 @default.
• W3048654315 cites W2093659327 @default.
• W3048654315 cites W2101616608 @default.
• W3048654315 cites W2108444995 @default.
• W3048654315 cites W2120010339 @default.
• W3048654315 cites W2122406360 @default.
• W3048654315 cites W2129925282 @default.
• W3048654315 cites W2136521447 @default.
• W3048654315 cites W2139097227 @default.
• W3048654315 cites W2139248078 @default.
• W3048654315 cites W2157376707 @default.
• W3048654315 cites W2165814086 @default.
• W3048654315 cites W2166221624 @default.
• W3048654315 cites W2166341146 @default.
• W3048654315 cites W2168373302 @default.
• W3048654315 cites W2238774085 @default.
• W3048654315 cites W2292975657 @default.
• W3048654315 cites W2322746726 @default.
• W3048654315 cites W2332055315 @default.
• W3048654315 cites W2389343900 @default.
• W3048654315 cites W2464328424 @default.
• W3048654315 cites W2587429794 @default.
• W3048654315 cites W2590429818 @default.
• W3048654315 cites W2614733772 @default.
• W3048654315 cites W2615693675 @default.
• W3048654315 cites W2620716110 @default.
• W3048654315 cites W2664868206 @default.
• W3048654315 cites W2747660904 @default.
• W3048654315 cites W2751620132 @default.
• W3048654315 cites W2756267081 @default.
• W3048654315 cites W2767119969 @default.
• W3048654315 cites W2787477673 @default.
• W3048654315 cites W2891137836 @default.
• W3048654315 cites W2944700800 @default.
• W3048654315 cites W2978729264 @default.
• W3048654315 cites W3003955947 @default.
• W3048654315 cites W3009327907 @default.
• W3048654315 doi "https://doi.org/10.1159/000509156" @default.
• W3048654315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32777789" @default.
• W3048654315 hasPublicationYear "2020" @default.
• W3048654315 type Work @default.
• W3048654315 sameAs 3048654315 @default.
• W3048654315 citedByCount "15" @default.
• W3048654315 countsByYear W30486543152020 @default.
• W3048654315 countsByYear W30486543152021 @default.
• W3048654315 countsByYear W30486543152022 @default.
• W3048654315 countsByYear W30486543152023 @default.
• W3048654315 crossrefType "journal-article" @default.
• W3048654315 hasAuthorship W3048654315A5002719929 @default.
• W3048654315 hasAuthorship W3048654315A5004401304 @default.
• W3048654315 hasAuthorship W3048654315A5006307929 @default.
• W3048654315 hasAuthorship W3048654315A5007806653 @default.
• W3048654315 hasAuthorship W3048654315A5025847886 @default.
• W3048654315 hasAuthorship W3048654315A5028712141 @default.
• W3048654315 hasAuthorship W3048654315A5040002157 @default.
• W3048654315 hasAuthorship W3048654315A5044074313 @default.
• W3048654315 hasAuthorship W3048654315A5059728206 @default.
• W3048654315 hasAuthorship W3048654315A5086252442 @default.

• next